메뉴 건너뛰기




Volumn 7, Issue 3, 2011, Pages 190-200

Prevention and Treatment of Diabetic Retinopathy: Evidence from Clinical trials and Perspectives

Author keywords

Anti VEGF agents; Diabetic retinopathy; Fenofibrates; Glycemic control; Renin angiotensin system; Statins

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; ENALAPRIL; FENOFIBRATE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NISOLDIPINE; PEGAPTANIB; RANIBIZUMAB; ROSIGLITAZONE; TRANDOLAPRIL; TRANDOLAPRIL PLUS VERAPAMIL; TRIACYLGLYCEROL; VASCULOTROPIN;

EID: 79959344912     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339911795843168     Document Type: Article
Times cited : (38)

References (134)
  • 1
    • 0024537989 scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years
    • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989; 107(2): 237-43.
    • (1989) Arch Ophthalmol , vol.107 , Issue.2 , pp. 237-243
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3    Davis, M.D.4    Demets, D.L.5
  • 2
    • 0021191759 scopus 로고
    • The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
    • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102(4): 527-32.
    • (1984) Arch Ophthalmol , vol.102 , Issue.4 , pp. 527-532
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3    Davis, M.D.4    Demets, D.L.5
  • 3
    • 2342466734 scopus 로고    scopus 로고
    • Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
    • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-53.
    • (2004) Diabetes Care , vol.27 , Issue.5 , pp. 1047-1053
    • Wild, S.1    Roglic, G.2    Green, A.3    Sicree, R.4    King, H.5
  • 4
    • 0031897103 scopus 로고    scopus 로고
    • Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994
    • Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21(4): 518-24.
    • (1998) Diabetes Care , vol.21 , Issue.4 , pp. 518-524
    • Harris, M.I.1    Flegal, K.M.2    Cowie, C.C.3
  • 5
    • 0030856406 scopus 로고    scopus 로고
    • The epidemic of NIDDM in Asian and Pacific Island populations: Prevalence and risk factors
    • Coughlan A, McCarty DJ, Jorgensen LN, Zimmet P. The epidemic of NIDDM in Asian and Pacific Island populations: prevalence and risk factors. Horm Metab Res 1997; 29(7): 323-31.
    • (1997) Horm Metab Res , vol.29 , Issue.7 , pp. 323-331
    • Coughlan, A.1    McCarty, D.J.2    Jorgensen, L.N.3    Zimmet, P.4
  • 6
    • 0008339691 scopus 로고
    • Nouveau mémoire sur la glycosurie
    • Bouchardat A. Nouveau mémoire sur la glycosurie. Ann de Thérap 1846, Suppl P: 162-311.
    • (1846) Ann De Thérap , Issue.SUPPL. , pp. 162-311
    • Bouchardat, A.1
  • 7
    • 0013663227 scopus 로고
    • Retinitis in glycosuria
    • Noyes; HD. Retinitis in glycosuria. Trans Am Ophthalmol Soc 1868; 1(4-5): 71-5.
    • (1868) Trans Am Ophthalmol Soc , vol.1 , Issue.4-5 , pp. 71-75
    • Noyes, H.D.1
  • 8
    • 0008329792 scopus 로고
    • On oedema or cystic disease of the retina
    • Nettleship E. On oedema or cystic disease of the retina. Roy Ophthalmol Lond Hosp Rep 1872; VII: 343-51.
    • (1872) Roy Ophthalmol Lond Hosp Rep , vol.7 , pp. 343-351
    • Nettleship, E.1
  • 12
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complication Trail Research Group
    • The Diabetes Control and Complication Trail Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977-86.
    • (1993) N Engl J Med , vol.329 , Issue.14 , pp. 977-986
  • 13
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321(7258): 405-12.
    • (2000) BMJ , vol.321 , Issue.7258 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 14
    • 0035134120 scopus 로고    scopus 로고
    • UKPDS 50: Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis
    • Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44(2): 156-63.
    • (2001) Diabetologia , vol.44 , Issue.2 , pp. 156-163
    • Stratton, I.M.1    Kohner, E.M.2    Aldington, S.J.3
  • 15
    • 0021136256 scopus 로고
    • The wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
    • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102(4): 520-6.
    • (1984) Arch Ophthalmol , vol.102 , Issue.4 , pp. 520-526
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3    Davis, M.D.4    Demets, D.L.5
  • 16
    • 0042932653 scopus 로고    scopus 로고
    • Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
    • Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110(9): 1677-82.
    • (2003) Ophthalmology , vol.110 , Issue.9 , pp. 1677-1682
    • Wilkinson, C.P.1    Ferris 3rd, F.L.2    Klein, R.E.3
  • 18
    • 1842554936 scopus 로고    scopus 로고
    • Diabetic retinopathy: Clinical findings and management
    • Viswanath K, McGavin DD. Diabetic retinopathy: clinical findings and management. Community Eye Health 2003; 16(46): 21-4.
    • (2003) Community Eye Health , vol.16 , Issue.46 , pp. 21-24
    • Viswanath, K.1    McGavin, D.D.2
  • 19
    • 0023034841 scopus 로고
    • An alternative method of grading diabetic retinopathy
    • Klein R, Klein BE, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology 1986; 93(9): 1183-7.
    • (1986) Ophthalmology , vol.93 , Issue.9 , pp. 1183-1187
    • Klein, R.1    Klein, B.E.2    Magli, Y.L.3
  • 20
    • 0037184495 scopus 로고    scopus 로고
    • Molecular understanding of hyperglycemia's adverse effects for diabetic complications
    • Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002; 288(20): 2579-88.
    • (2002) JAMA , vol.288 , Issue.20 , pp. 2579-2588
    • Sheetz, M.J.1    King, G.L.2
  • 21
    • 78651338445 scopus 로고    scopus 로고
    • Standards of medical care in diabetes--2011
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011; 34 (Suppl 1): S11-61.
    • (2011) Diabetes Care , vol.34 , Issue.SUPPL. 1
  • 22
    • 39649088467 scopus 로고    scopus 로고
    • Relation between fasting glucose and retinopathy for diagnosis of diabetes: Three populationbased cross-sectional studies
    • Wong TY, Liew G, Tapp RJ, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three populationbased cross-sectional studies. Lancet 2008; 371(9614): 736-43.
    • (2008) Lancet , vol.371 , Issue.9614 , pp. 736-743
    • Wong, T.Y.1    Liew, G.2    Tapp, R.J.3
  • 23
    • 34548391344 scopus 로고    scopus 로고
    • Utility of A1C for diabetes screening in the 1999 2004 NHANES population
    • Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 2007; 30(9): 2233-5.
    • (2007) Diabetes Care , vol.30 , Issue.9 , pp. 2233-2235
    • Buell, C.1    Kermah, D.2    Davidson, M.B.3
  • 24
    • 70449378172 scopus 로고    scopus 로고
    • Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds
    • Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 2009; 32(11): 2027-32.
    • (2009) Diabetes Care , vol.32 , Issue.11 , pp. 2027-2032
    • Cheng, Y.J.1    Gregg, E.W.2    Geiss, L.S.3
  • 25
    • 0027286787 scopus 로고
    • Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes
    • Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993; 341(8856): 1306-9.
    • (1993) Lancet , vol.341 , Issue.8856 , pp. 1306-1309
    • Wang, P.H.1    Lau, J.2    Chalmers, T.C.3
  • 26
    • 0031917205 scopus 로고    scopus 로고
    • Risk factors for highrisk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18
    • Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for highrisk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998; 39(2): 233-52.
    • (1998) Invest Ophthalmol Vis Sci , vol.39 , Issue.2 , pp. 233-252
    • Davis, M.D.1    Fisher, M.R.2    Gangnon, R.E.3
  • 27
    • 58149252632 scopus 로고    scopus 로고
    • Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial
    • White NH, Sun W, Cleary PA, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008; 126(12): 1707-15.
    • (2008) Arch Ophthalmol , vol.126 , Issue.12 , pp. 1707-1715
    • White, N.H.1    Sun, W.2    Cleary, P.A.3
  • 28
    • 77956467450 scopus 로고    scopus 로고
    • Metabolic memory: A vascular perspective
    • Jax TW. Metabolic memory: a vascular perspective. Cardiovasc Diabetol 2010; 9: 51.
    • (2010) Cardiovasc Diabetol , vol.9 , pp. 51
    • Jax, T.W.1
  • 29
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-53.
    • (1998) Lancet , vol.352 , Issue.9131 , pp. 837-853
  • 30
    • 0034071036 scopus 로고    scopus 로고
    • Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients
    • Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23(Suppl 2): B21-9.
    • (2000) Diabetes Care , vol.23 , Issue.SUPPL. 2
    • Shichiri, M.1    Kishikawa, H.2    Ohkubo, Y.3    Wake, N.4
  • 31
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358(24): 2560-72.
    • (2008) N Engl J Med , vol.358 , Issue.24 , pp. 2560-2572
    • Patel, A.1    Macmahon, S.2    Chalmers, J.3
  • 32
    • 77955585592 scopus 로고    scopus 로고
    • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial
    • Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376(9739): 419-30.
    • (2010) Lancet , vol.376 , Issue.9739 , pp. 419-430
    • Ismail-Beigi, F.1    Craven, T.2    Banerji, M.A.3
  • 33
    • 77954654472 scopus 로고    scopus 로고
    • Effects of medical therapies on retinopathy progression in type 2 diabetes
    • Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363(3): 233-44.
    • (2010) N Engl J Med , vol.363 , Issue.3 , pp. 233-244
    • Chew, E.Y.1    Ambrosius, W.T.2    Davis, M.D.3
  • 34
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360(2): 129-39.
    • (2009) N Engl J Med , vol.360 , Issue.2 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 35
    • 77954159481 scopus 로고    scopus 로고
    • Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial
    • Riddle MC, Ambrosius WT, Brillon DJ, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010; 33(5): 983-90.
    • (2010) Diabetes Care , vol.33 , Issue.5 , pp. 983-990
    • Riddle, M.C.1    Ambrosius, W.T.2    Brillon, D.J.3
  • 36
    • 54849146100 scopus 로고    scopus 로고
    • Intensive glucose control in type 2 diabetes
    • author reply 20-1
    • Jenny-Avital ER. Intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359(14): 1519; author reply 20-1.
    • (2008) N Engl J Med , vol.359 , Issue.14
    • Jenny-Avital, E.R.1
  • 37
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356(24): 2457-71.
    • (2007) N Engl J Med , vol.356 , Issue.24 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2
  • 38
    • 34548580881 scopus 로고    scopus 로고
    • Long-term risk of cardiovascular events with rosiglitazone: A meta-analysis
    • Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007; 298(10): 1189-95.
    • (2007) JAMA , vol.298 , Issue.10 , pp. 1189-1195
    • Singh, S.1    Loke, Y.K.2    Furberg, C.D.3
  • 39
    • 9244261055 scopus 로고    scopus 로고
    • Hypertensive retinopathy
    • Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004; 351(22): 2310-7.
    • (2004) N Engl J Med , vol.351 , Issue.22 , pp. 2310-2317
    • Wong, T.Y.1    Mitchell, P.2
  • 40
    • 0021803232 scopus 로고
    • Hypertension, orthostatic hypotension and the microvascular complications of diabetes
    • Krolewski AS, Warram JH, Cupples A, et al. Hypertension, orthostatic hypotension and the microvascular complications of diabetes. J Chronic Dis 1985; 38(4): 319-26.
    • (1985) J Chronic Dis , vol.38 , Issue.4 , pp. 319-326
    • Krolewski, A.S.1    Warram, J.H.2    Cupples, A.3
  • 41
    • 0029301644 scopus 로고
    • A cohort study of the relationship of diabetic retinopathy to blood pressure
    • Klein BE, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 1995; 113(5): 601-6.
    • (1995) Arch Ophthalmol , vol.113 , Issue.5 , pp. 601-606
    • Klein, B.E.1    Klein, R.2    Moss, S.E.3    Palta, M.4
  • 42
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331(22): 1480-7.
    • (1994) N Engl J Med , vol.331 , Issue.22 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3
  • 43
    • 0026625948 scopus 로고
    • Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus
    • Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 1992; 20(2): 253-63.
    • (1992) Hypertension , vol.20 , Issue.2 , pp. 253-263
    • Hsueh, W.A.1    Anderson, P.W.2
  • 44
    • 0030906769 scopus 로고    scopus 로고
    • The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: A 5 year follow-up study of 442 adult patients in routine care
    • Agardh CD, Agardh E, Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract 1997; 35(2-3): 113-21.
    • (1997) Diabetes Res Clin Pract , vol.35 , Issue.2-3 , pp. 113-121
    • Agardh, C.D.1    Agardh, E.2    Torffvit, O.3
  • 45
    • 0034139725 scopus 로고    scopus 로고
    • Insulin secretory response in healthy adult offspring of hypertensive parents
    • Roy R, Jain M, Maheshwari S, Goyal RK. Insulin secretory response in healthy adult offspring of hypertensive parents. J Assoc Physicians India 2000; 48(2): 207-9.
    • (2000) J Assoc Physicians India , vol.48 , Issue.2 , pp. 207-209
    • Roy, R.1    Jain, M.2    Maheshwari, S.3    Goyal, R.K.4
  • 46
    • 0025342682 scopus 로고
    • Blood pressure and microvascular complications in type 1 (insulin de pendent) diabetic patients without hypertension
    • Le Floch JP, Christin S, Bertherat J, Perlemuter L, Hazard J. Blood pressure and microvascular complications in type 1 (insulin de pendent) diabetic patients without hypertension. Diabetes Metab 1990; 16(1): 26-9.
    • (1990) Diabetes Metab , vol.16 , Issue.1 , pp. 26-29
    • Le Floch, J.P.1    Christin, S.2    Bertherat, J.3    Perlemuter, L.4    Hazard, J.5
  • 47
    • 0026695830 scopus 로고
    • High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients
    • Cignarelli M, De Cicco ML, Damato A, et al. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 1992; 15(8): 1002-8.
    • (1992) Diabetes Care , vol.15 , Issue.8 , pp. 1002-1008
    • Cignarelli, M.1    de Cicco, M.L.2    Damato, A.3
  • 48
    • 0032701429 scopus 로고    scopus 로고
    • Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics
    • Wan Nazaimoon WM, Letchuman R, Noraini N, et al. Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics. Diabetes Res Clin Pract 1999; 46(3): 213-21.
    • (1999) Diabetes Res Clin Pract , vol.46 , Issue.3 , pp. 213-221
    • Wan, N.W.M.1    Letchuman, R.2    Noraini, N.3
  • 49
    • 0026934966 scopus 로고
    • Vascular complications in noninsulin dependent diabetes mellitus (NIDDM) in Srinagarind Hospital, Khon Kaen
    • Bhuripanyo P, Graisopa S, Suwanwatana C, et al. Vascular complications in noninsulin dependent diabetes mellitus (NIDDM) in Srinagarind Hospital, Khon Kaen. J Med Assoc Thai 1992; 75(10): 570-7.
    • (1992) J Med Assoc Thai , vol.75 , Issue.10 , pp. 570-577
    • Bhuripanyo, P.1    Graisopa, S.2    Suwanwatana, C.3
  • 50
    • 0025972857 scopus 로고
    • The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy
    • Kostraba JN, Klein R, Dorman JS, et al. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 1991; 133(4): 381-91.
    • (1991) Am J Epidemiol , vol.133 , Issue.4 , pp. 381-391
    • Kostraba, J.N.1    Klein, R.2    Dorman, J.S.3
  • 51
    • 0025186672 scopus 로고
    • Blood pressure and retinopathy in type I diabetes
    • Chase HP, Garg SK, Jackson WE, et al. Blood pressure and retinopathy in type I diabetes. Ophthalmology 1990; 97(2): 155-9.
    • (1990) Ophthalmology , vol.97 , Issue.2 , pp. 155-159
    • Chase, H.P.1    Garg, S.K.2    Jackson, W.E.3
  • 52
    • 0022365329 scopus 로고
    • Multiple factors in the prediction of risk of proliferative diabetic retinopathy
    • Rand LI, Krolewski AS, Aiello LM, et al. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985; 313(23): 1433-8.
    • (1985) N Engl J Med , vol.313 , Issue.23 , pp. 1433-1438
    • Rand, L.I.1    Krolewski, A.S.2    Aiello, L.M.3
  • 53
    • 0018864599 scopus 로고
    • Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians
    • Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med 1980; 302(12): 645-50.
    • (1980) N Engl J Med , vol.302 , Issue.12 , pp. 645-650
    • Knowler, W.C.1    Bennett, P.H.2    Ballintine, E.J.3
  • 54
    • 0026803376 scopus 로고
    • Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors
    • Lee ET, Lee VS, Kingsley RM, et al. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care 1992; 15(11): 1620-7.
    • (1992) Diabetes Care , vol.15 , Issue.11 , pp. 1620-1627
    • Lee, E.T.1    Lee, V.S.2    Kingsley, R.M.3
  • 55
    • 34250694084 scopus 로고    scopus 로고
    • Arterial siffness and diastolic blood pressure: What is the connection?
    • Franklin SS. Arterial siffness and diastolic blood pressure: what is the connection? Artery Res 2006; 1: 6.
    • (2006) Artery Res , vol.1 , pp. 6
    • Franklin, S.S.1
  • 56
    • 77956344451 scopus 로고    scopus 로고
    • Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events
    • Chrysant SG, Chrysant GS. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events. Am J Cardiol 2010; 106(6): 825-9.
    • (2010) Am J Cardiol , vol.106 , Issue.6 , pp. 825-829
    • Chrysant, S.G.1    Chrysant, G.S.2
  • 57
    • 0031793875 scopus 로고    scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
    • Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105(10): 1801-15.
    • (1998) Ophthalmology , vol.105 , Issue.10 , pp. 1801-1815
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3    Cruickshanks, K.J.4
  • 58
    • 29744445053 scopus 로고
    • Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics
    • The Diabetes Drafting Group
    • The Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetologia 1985; 28 (Suppl): 615-40.
    • (1985) Diabetologia , vol.28 , Issue.SUPPL. , pp. 615-640
  • 59
    • 0027293829 scopus 로고
    • Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus
    • Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 1993; 100(8): 1133-9.
    • (1993) Ophthalmology , vol.100 , Issue.8 , pp. 1133-1139
    • Marshall, G.1    Garg, S.K.2    Jackson, W.E.3    Holmes, D.L.4    Chase, H.P.5
  • 60
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317(7160): 703-13.
    • (1998) BMJ , vol.317 , Issue.7160 , pp. 703-713
  • 61
    • 0034641550 scopus 로고    scopus 로고
    • Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
    • Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321(7258):412-9.
    • (2000) BMJ , vol.321 , Issue.7258 , pp. 412-419
    • Adler, A.I.1    Stratton, I.M.2    Neil, H.A.3
  • 62
    • 54949133248 scopus 로고    scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes
    • Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008; 115(11): 1859-68.
    • (2008) Ophthalmology , vol.115 , Issue.11 , pp. 1859-1868
    • Klein, R.1    Knudtson, M.D.2    Lee, K.E.3    Gangnon, R.4    Klein, B.E.5
  • 63
    • 8144221037 scopus 로고    scopus 로고
    • Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: Ukpds 69
    • Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 2004; 122(11): 1631-40.
    • (2004) Arch Ophthalmol , vol.122 , Issue.11 , pp. 1631-1640
    • Matthews, D.R.1    Stratton, I.M.2    Aldington, S.J.3    Holman, R.R.4    Kohner, E.M.5
  • 64
    • 53749091595 scopus 로고    scopus 로고
    • Longterm follow-up after tight control of blood pressure in type 2 diabetes
    • Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Longterm follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359(15): 1565-76.
    • (2008) N Engl J Med , vol.359 , Issue.15 , pp. 1565-1576
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3    Neil, H.A.4    Matthews, D.R.5
  • 65
    • 0034074955 scopus 로고    scopus 로고
    • Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
    • Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000; 23(Suppl 2): B54-64.
    • (2000) Diabetes Care , vol.23 , Issue.SUPPL. 2
    • Estacio, R.O.1    Jeffers, B.W.2    Gifford, N.3    Schrier, R.W.4
  • 66
    • 77951735232 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure control in type 2 diabetes mellitus
    • Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362(17): 1575-85.
    • (2010) N Engl J Med , vol.362 , Issue.17 , pp. 1575-1585
    • Cushman, W.C.1    Evans, G.W.2    Byington, R.P.3
  • 67
    • 0023991545 scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy: VIII. The incidence of retinal photocoagulation
    • Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: VIII. The incidence of retinal photocoagulation. J Diabetes Complications 1988; 2(2): 79-87.
    • (1988) J Diabetes Complications , vol.2 , Issue.2 , pp. 79-87
    • Klein, R.1    Moss, S.E.2    Klein, B.E.3    Davis, M.D.4    Demets, D.L.5
  • 68
    • 0036673902 scopus 로고    scopus 로고
    • Blood pressure, lipids, and obesity are associated with retinopathy: The hoorn study
    • van Leiden HA, Dekker JM, Moll AC, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care 2002; 25(8): 1320-5.
    • (2002) Diabetes Care , vol.25 , Issue.8 , pp. 1320-1325
    • van Leiden, H.A.1    Dekker, J.M.2    Moll, A.C.3
  • 69
    • 0024471810 scopus 로고
    • The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema
    • Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989; 96(10): 1501-10.
    • (1989) Ophthalmology , vol.96 , Issue.10 , pp. 1501-1510
    • Klein, R.1    Moss, S.E.2    Klein, B.E.3    Davis, M.D.4    Demets, D.L.5
  • 70
    • 0032746282 scopus 로고    scopus 로고
    • Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration?
    • Klein BE, Klein R, Moss SE. Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration? Am J Ophthalmol 1999; 128(5): 652-4.
    • (1999) Am J Ophthalmol , vol.128 , Issue.5 , pp. 652-654
    • Klein, B.E.1    Klein, R.2    Moss, S.E.3
  • 71
    • 0030280257 scopus 로고    scopus 로고
    • Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group
    • Ferris FL, 3rd, Chew EY, Hoogwerf BJ. Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 1996; 19(11): 1291-3.
    • (1996) Diabetes Care , vol.19 , Issue.11 , pp. 1291-1293
    • Ferris 3rd, F.L.1    Chew, E.Y.2    Hoogwerf, B.J.3
  • 72
    • 0242286190 scopus 로고    scopus 로고
    • Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels
    • Cusick M, Chew EY, Chan CC, et al. Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology 2003; 110(11): 2126-33.
    • (2003) Ophthalmology , vol.110 , Issue.11 , pp. 2126-2133
    • Cusick, M.1    Chew, E.Y.2    Chan, C.C.3
  • 73
    • 1842608809 scopus 로고    scopus 로고
    • Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema
    • Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 2004; 137(4): 675-82.
    • (2004) Am J Ophthalmol , vol.137 , Issue.4 , pp. 675-682
    • Gupta, A.1    Gupta, V.2    Thapar, S.3    Bhansali, A.4
  • 74
    • 1842607517 scopus 로고    scopus 로고
    • Association of dyslipidemia and effects of statins on nonmacrovascular diseases
    • Baghdasarian SB, Jneid H, Hoogwerf BJ. Association of dyslipidemia and effects of statins on nonmacrovascular diseases. Clin Ther 2004; 26(3): 337-51.
    • (2004) Clin Ther , vol.26 , Issue.3 , pp. 337-351
    • Baghdasarian, S.B.1    Jneid, H.2    Hoogwerf, B.J.3
  • 75
    • 0018897766 scopus 로고
    • Organised macular plaques in exudative diabetic maculopathy
    • Sigurdsson R, Begg IS. Organised macular plaques in exudative diabetic maculopathy. Br J Ophthalmol 1980; 64(6): 392-7.
    • (1980) Br J Ophthalmol , vol.64 , Issue.6 , pp. 392-397
    • Sigurdsson, R.1    Begg, I.S.2
  • 76
    • 0025995666 scopus 로고
    • The effects of lipid lowering on diabetic retinopathy
    • Gordon B, Chang S, Kavanagh M, et al. The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol 1991; 112(4): 385-91.
    • (1991) Am J Ophthalmol , vol.112 , Issue.4 , pp. 385-391
    • Gordon, B.1    Chang, S.2    Kavanagh, M.3
  • 77
    • 0026093735 scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate
    • Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991; 98(8): 1261-5.
    • (1991) Ophthalmology , vol.98 , Issue.8 , pp. 1261-1265
    • Klein, B.E.1    Moss, S.E.2    Klein, R.3    Surawicz, T.S.4
  • 78
    • 0030942183 scopus 로고    scopus 로고
    • Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus
    • De la Cruz JP, Moreno A, Munoz M, Garcia Campos JM, Sanchez de la Cuesta F. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. J Pharmacol Exp Ther 1997; 280(1): 454-9.
    • (1997) J Pharmacol Exp Ther , vol.280 , Issue.1 , pp. 454-459
    • de la Cruz, J.P.1    Moreno, A.2    Munoz, M.3    Garcia, C.4    de la Sanchez, J.M.5    Cuesta, F.6
  • 79
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364(9435): 685-96.
    • (2004) Lancet , vol.364 , Issue.9435 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3
  • 81
    • 20144373625 scopus 로고    scopus 로고
    • Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner
    • Arakawa R, Tamehiro N, Nishimaki-Mogami T, Ueda K, Yokoyama S. Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner. Arterioscler Thromb Vasc Biol 2005; 25(6): 1193-7.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , Issue.6 , pp. 1193-1197
    • Arakawa, R.1    Tamehiro, N.2    Nishimaki-Mogami, T.3    Ueda, K.4    Yokoyama, S.5
  • 82
    • 33645076793 scopus 로고    scopus 로고
    • Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism
    • Fruchart JC, Duriez P. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc) 2006; 42(1): 39-64.
    • (2006) Drugs Today (Barc) , vol.42 , Issue.1 , pp. 39-64
    • Fruchart, J.C.1    Duriez, P.2
  • 83
    • 59049099033 scopus 로고    scopus 로고
    • Fenofibrate: Treatment of hyperlipidemia and beyond
    • Rosenson RS. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev Cardiovasc Ther 2008; 6(10): 1319-30.
    • (2008) Expert Rev Cardiovasc Ther , vol.6 , Issue.10 , pp. 1319-1330
    • Rosenson, R.S.1
  • 84
    • 36049001784 scopus 로고    scopus 로고
    • Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): A randomised controlled trial
    • Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370(9600): 1687-97.
    • (2007) Lancet , vol.370 , Issue.9600 , pp. 1687-1697
    • Keech, A.C.1    Mitchell, P.2    Summanen, P.A.3
  • 85
    • 57649104652 scopus 로고    scopus 로고
    • After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: Implications for fenofibrate
    • Sacks FM. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate. Am J Cardiol 2008; 102(12A): 34L-40L.
    • (2008) Am J Cardiol , vol.102 , Issue.12 A
    • Sacks, F.M.1
  • 86
    • 34250694874 scopus 로고    scopus 로고
    • Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE)
    • Chew EY, Ambrosius WT, Howard LT, et al. Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol 2007; 99(12A): 103i-11i.
    • (2007) Am J Cardiol , vol.99
    • Chew, E.Y.1    Ambrosius, W.T.2    Howard, L.T.3
  • 87
    • 0027525040 scopus 로고
    • Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations
    • Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993; 265(4 Pt 2): F477-86.
    • (1993) Am J Physiol , vol.265 , Issue.4 PART 2
    • Anderson, S.1    Jung, F.F.2    Ingelfinger, J.R.3
  • 88
    • 0023129675 scopus 로고
    • Implications of local angiotensin production in cardiovascular physiology and pharmacology
    • Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987; 59(2): 59A-65A.
    • (1987) Am J Cardiol , vol.59 , Issue.2
    • Dzau, V.J.1
  • 89
    • 0142182710 scopus 로고    scopus 로고
    • Angiotensin II and oxidative stress: An unholy alliance
    • Ritz E, Haxsen V. Angiotensin II and oxidative stress: an unholy alliance. J Am Soc Nephrol 2003; 14(11): 2985-7.
    • (2003) J Am Soc Nephrol , vol.14 , Issue.11 , pp. 2985-2987
    • Ritz, E.1    Haxsen, V.2
  • 90
    • 7544244885 scopus 로고    scopus 로고
    • Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability
    • Newton CR, Curran B, Victorino GP. Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability. Surgery 2004; 136(5): 1054-60.
    • (2004) Surgery , vol.136 , Issue.5 , pp. 1054-1060
    • Newton, C.R.1    Curran, B.2    Victorino, G.P.3
  • 91
    • 2542463937 scopus 로고    scopus 로고
    • Angiotensin II type 2 receptor effect on microvascular hydraulic permeability
    • Newton CR, Curran B, Victorino GP. Angiotensin II type 2 receptor effect on microvascular hydraulic permeability. J Surg Res 2004; 120(1): 83-8.
    • (2004) J Surg Res , vol.120 , Issue.1 , pp. 83-88
    • Newton, C.R.1    Curran, B.2    Victorino, G.P.3
  • 92
    • 0030012833 scopus 로고    scopus 로고
    • Regulation of the hypothalmic-pituitaryadrenal axis and vasopressin secretion. Role of angiotensin II
    • Aguilera G, Kiss A. Regulation of the hypothalmic-pituitaryadrenal axis and vasopressin secretion. Role of angiotensin II. Adv Exp Med Biol 1996; 396: 105-12.
    • (1996) Adv Exp Med Biol , vol.396 , pp. 105-112
    • Aguilera, G.1    Kiss, A.2
  • 93
    • 0036085160 scopus 로고    scopus 로고
    • Angiotensin II stimulates migration of retinal microvascular pericytes: Involvement of TGF-beta and PDGF-BB
    • Nadal JA, Scicli GM, Carbini LA, Scicli AG. Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB. Am J Physiol Heart Circ Physiol 2002; 282(2): H739-48.
    • (2002) Am J Physiol Heart Circ Physiol , vol.282 , Issue.2
    • Nadal, J.A.1    Scicli, G.M.2    Carbini, L.A.3    Scicli, A.G.4
  • 94
    • 0036190235 scopus 로고    scopus 로고
    • Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
    • Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, et al. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Diabetologia 2002; 45(2): 203-9.
    • (2002) Diabetologia , vol.45 , Issue.2 , pp. 203-209
    • Hogeboom van Buggenum, I.M.1    Polak, B.C.2    Reichert-Thoen, J.W.3
  • 95
    • 33745518791 scopus 로고    scopus 로고
    • Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: Effects of blood pressure control and beyond
    • Clermont A, Bursell SE, Feener EP. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond. J Hypertens Suppl 2006; 24(1): S73-80.
    • (2006) J Hypertens Suppl , vol.24 , Issue.1
    • Clermont, A.1    Bursell, S.E.2    Feener, E.P.3
  • 96
    • 0030909314 scopus 로고    scopus 로고
    • Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
    • Wu LL, Cox A, Roe CJ, et al. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 1997; 51(5): 1553-67.
    • (1997) Kidney Int , vol.51 , Issue.5 , pp. 1553-1567
    • Wu, L.L.1    Cox, A.2    Roe, C.J.3
  • 97
    • 12644267322 scopus 로고    scopus 로고
    • Basement membrane abnormalities in human eyes with diabetic retinopathy
    • Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 1996; 44(12): 1469-79.
    • (1996) J Histochem Cytochem , vol.44 , Issue.12 , pp. 1469-1479
    • Ljubimov, A.V.1    Burgeson, R.E.2    Butkowski, R.J.3
  • 98
    • 79551676689 scopus 로고    scopus 로고
    • The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy
    • Jeganathan VS. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy. Curr Pharm Biotechnol 2011; 12(3): 392-5.
    • (2011) Curr Pharm Biotechnol , vol.12 , Issue.3 , pp. 392-395
    • Jeganathan, V.S.1
  • 99
    • 70449484613 scopus 로고    scopus 로고
    • The evolving story of the RAAS in hypertension, diabetes and CV disease: Moving from macrovascular to microvascular targets
    • Steckelings UM, Rompe F, Kaschina E, Unger T. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 2009; 23(6): 693-703.
    • (2009) Fundam Clin Pharmacol , vol.23 , Issue.6 , pp. 693-703
    • Steckelings, U.M.1    Rompe, F.2    Kaschina, E.3    Unger, T.4
  • 100
    • 33947625093 scopus 로고    scopus 로고
    • Prospects for angiotensin receptor blockers in diabetic retinopathy
    • Sjolie AK. Prospects for angiotensin receptor blockers in diabetic retinopathy. Diabetes Res Clin Pract 2007; 76(Suppl 1): S31-9.
    • (2007) Diabetes Res Clin Pract , vol.76 , Issue.SUPPL. 1
    • Sjolie, A.K.1
  • 101
    • 33747893515 scopus 로고    scopus 로고
    • Pigment epitheliumderived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy
    • Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Pigment epitheliumderived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 2006; 37(1): 1-12.
    • (2006) J Mol Endocrinol , vol.37 , Issue.1 , pp. 1-12
    • Zhang, S.X.1    Wang, J.J.2    Gao, G.3    Parke, K.4    Ma, J.X.5
  • 102
    • 71549153783 scopus 로고    scopus 로고
    • Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes
    • Gao BB, Phipps JA, Bursell D, Clermont AC, Feener EP. Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes. J Proteome Res 2009; 8(12): 5541-9.
    • (2009) J Proteome Res , vol.8 , Issue.12 , pp. 5541-5549
    • Gao, B.B.1    Phipps, J.A.2    Bursell, D.3    Clermont, A.C.4    Feener, E.P.5
  • 103
    • 0032477583 scopus 로고    scopus 로고
    • Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus
    • Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998; 351(9095): 28-31.
    • (1998) Lancet , vol.351 , Issue.9095 , pp. 28-31
    • Chaturvedi, N.1    Sjolie, A.K.2    Stephenson, J.M.3
  • 104
    • 53749100124 scopus 로고    scopus 로고
    • Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: Randomised, placebocontrolled trials
    • Chaturvedi N, Porta M, Klein R, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebocontrolled trials. Lancet 2008; 372(9647): 1394-402.
    • (2008) Lancet , vol.372 , Issue.9647 , pp. 1394-1402
    • Chaturvedi, N.1    Porta, M.2    Klein, R.3
  • 106
    • 67649635807 scopus 로고    scopus 로고
    • Renal and retinal effects of enalapril and losartan in type 1 diabetes
    • Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009; 361(1): 40-51.
    • (2009) N Engl J Med , vol.361 , Issue.1 , pp. 40-51
    • Mauer, M.1    Zinman, B.2    Gardiner, R.3
  • 107
    • 33845257120 scopus 로고    scopus 로고
    • Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: A post hoc analysis of the BENEDICT trial
    • Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. J Am Soc Nephrol 2006; 17(12): 3472-81.
    • (2006) J Am Soc Nephrol , vol.17 , Issue.12 , pp. 3472-3481
    • Ruggenenti, P.1    Perna, A.2    Ganeva, M.3    Ene-Iordache, B.4    Remuzzi, G.5
  • 108
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370(9590): 829-40.
    • (2007) Lancet , vol.370 , Issue.9590 , pp. 829-840
    • Patel, A.1    Macmahon, S.2    Chalmers, J.3
  • 109
    • 53749108177 scopus 로고    scopus 로고
    • Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECTProtect 2): A randomised placebo-controlled trial
    • Sjolie AK, Klein R, Porta M, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECTProtect 2): a randomised placebo-controlled trial. Lancet 2008; 372(9647): 1385-93.
    • (2008) Lancet , vol.372 , Issue.9647 , pp. 1385-1393
    • Sjolie, A.K.1    Klein, R.2    Porta, M.3
  • 110
    • 79959330386 scopus 로고    scopus 로고
    • Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: A prespecified analysis of the benedict trial
    • Ruggenenti P, Iliev I, Filipponi M, et al. Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial. J Ophthalmol 2010; 2010: 106384.
    • (2010) J Ophthalmol , vol.2010 , pp. 106384
    • Ruggenenti, P.1    Iliev, I.2    Filipponi, M.3
  • 111
    • 0031884211 scopus 로고    scopus 로고
    • Primary prevention of renal failure in diabetic patients: The Bergamo Nephrologic Diabetes Complication Trial
    • Ruggenenti P, Remuzzi G. Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial. J Hypertens Suppl 1998; 16(1): S95-7.
    • (1998) J Hypertens Suppl , vol.16 , Issue.1
    • Ruggenenti, P.1    Remuzzi, G.2
  • 112
    • 0036179104 scopus 로고    scopus 로고
    • Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate
    • Tolentino MJ, McLeod DS, Taomoto M, et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol 2002; 133(3): 373-85.
    • (2002) Am J Ophthalmol , vol.133 , Issue.3 , pp. 373-385
    • Tolentino, M.J.1    McLeod, D.S.2    Taomoto, M.3
  • 113
    • 0033753370 scopus 로고    scopus 로고
    • Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
    • Gilbert RE, Kelly DJ, Cox AJ, et al. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia 2000; 43(11): 1360-7.
    • (2000) Diabetologia , vol.43 , Issue.11 , pp. 1360-1367
    • Gilbert, R.E.1    Kelly, D.J.2    Cox, A.J.3
  • 114
    • 0037220601 scopus 로고    scopus 로고
    • The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: Transgenic and interventional studies
    • Moravski CJ, Skinner SL, Stubbs AJ, et al. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol 2003; 162(1): 151-60.
    • (2003) Am J Pathol , vol.162 , Issue.1 , pp. 151-160
    • Moravski, C.J.1    Skinner, S.L.2    Stubbs, A.J.3
  • 115
    • 0041924832 scopus 로고    scopus 로고
    • Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin
    • Sarlos S, Rizkalla B, Moravski CJ, et al. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 2003; 163(3): 879-87.
    • (2003) Am J Pathol , vol.163 , Issue.3 , pp. 879-887
    • Sarlos, S.1    Rizkalla, B.2    Moravski, C.J.3
  • 116
    • 0028123090 scopus 로고
    • Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
    • Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118(4): 445-50.
    • (1994) Am J Ophthalmol , vol.118 , Issue.4 , pp. 445-450
    • Adamis, A.P.1    Miller, J.W.2    Bernal, M.T.3
  • 117
    • 29644444716 scopus 로고    scopus 로고
    • Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    • Adamis AP, Altaweel M, Bressler NM, et al. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006; 113(1): 23-8.
    • (2006) Ophthalmology , vol.113 , Issue.1 , pp. 23-28
    • Adamis, A.P.1    Altaweel, M.2    Bressler, N.M.3
  • 118
    • 56649123212 scopus 로고    scopus 로고
    • Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis
    • Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 2008; 300(19): 2277-85.
    • (2008) JAMA , vol.300 , Issue.19 , pp. 2277-2285
    • Nalluri, S.R.1    Chu, D.2    Keresztes, R.3    Zhu, X.4    Wu, S.5
  • 119
    • 0037154304 scopus 로고    scopus 로고
    • Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulinresistant and diabetic States: A possible explanation for impaired collateral formation in cardiac tissue
    • Chou E, Suzuma I, Way KJ, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulinresistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105(3): 373-9.
    • (2002) Circulation , vol.105 , Issue.3 , pp. 373-379
    • Chou, E.1    Suzuma, I.2    Way, K.J.3
  • 120
    • 0037407757 scopus 로고    scopus 로고
    • VEGF164 is proinflammatory in the diabetic retina
    • Ishida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 2003; 44(5): 2155-62.
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , Issue.5 , pp. 2155-2162
    • Ishida, S.1    Usui, T.2    Yamashiro, K.3
  • 121
    • 25844513658 scopus 로고    scopus 로고
    • A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
    • Cunningham ET, Jr., Adamis AP, Altaweel M, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005; 112(10): 1747-57.
    • (2005) Ophthalmology , vol.112 , Issue.10 , pp. 1747-1757
    • Cunningham Jr., E.T.1    Adamis, A.P.2    Altaweel, M.3
  • 122
    • 34548231059 scopus 로고    scopus 로고
    • Strategies for blocking angiogenesis in diabetic retinopathy: From basic science to clinical practice
    • Hernandez C, Simo R. Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opin Investig Drugs 2007; 16(8): 1209-26.
    • (2007) Expert Opin Investig Drugs , vol.16 , Issue.8 , pp. 1209-1226
    • Hernandez, C.1    Simo, R.2
  • 123
    • 35548946193 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
    • Kumar A, Sinha S. Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population. Indian J Ophthalmol 2007; 55(6): 451-5.
    • (2007) Indian J Ophthalmol , vol.55 , Issue.6 , pp. 451-455
    • Kumar, A.1    Sinha, S.2
  • 124
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1419-31.
    • (2006) N Engl J Med , vol.355 , Issue.14 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 125
    • 33750314559 scopus 로고    scopus 로고
    • Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: Year 1 results of the FOCUS Study
    • Heier JS, Boyer DS, Ciulla TA, et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol 2006; 124(11): 1532-42.
    • (2006) Arch Ophthalmol , vol.124 , Issue.11 , pp. 1532-1542
    • Heier, J.S.1    Boyer, D.S.2    Ciulla, T.A.3
  • 126
    • 79251606719 scopus 로고    scopus 로고
    • Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): A 12- month, randomized, controlled, double-masked, multicenter phase II study
    • Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12- month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010; 33(11): 2399-405.
    • (2010) Diabetes Care , vol.33 , Issue.11 , pp. 2399-2405
    • Massin, P.1    Bandello, F.2    Garweg, J.G.3
  • 127
    • 67650424032 scopus 로고    scopus 로고
    • Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: Our experience after 2,000 injections
    • Ladas ID, Karagiannis DA, Rouvas AA, et al. Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections. Retina 2009; 29(3): 313-8.
    • (2009) Retina , vol.29 , Issue.3 , pp. 313-318
    • Ladas, I.D.1    Karagiannis, D.A.2    Rouvas, A.A.3
  • 128
    • 79959332423 scopus 로고    scopus 로고
    • Ranibizumab Alone or Adjunctive to Laser vs Laser Monotherapy in Diabetic Macular Edema: Twelve-Month Results of the RESTORE Study
    • RESTORE Study Group, Chicago, USA
    • RESTORE Study Group. Ranibizumab Alone or Adjunctive to Laser vs Laser Monotherapy in Diabetic Macular Edema: Twelve-Month Results of the RESTORE Study. Annual Meeting of the American Academy of Ophthalmology; Chicago, USA 2010.
    • (2010) Annual Meeting of the American Academy of Ophthalmology
  • 129
    • 79959352011 scopus 로고    scopus 로고
    • Treatment of proliferative diabetic retinopathy with anti-VEGF agents
    • [129], [Epub ahead of print]
    • [129] Salam A, Mathew R, Sivaprasad S. Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmol 2011; [Epub ahead of print]
    • (2011) Acta Ophthalmol
    • Salam, A.1    Mathew, R.2    Sivaprasad, S.3
  • 130
    • 50549220514 scopus 로고
    • Diabetic Retinopathy and Rheumatoid Arthritis
    • Powell ED, Field RA. Diabetic Retinopathy and Rheumatoid Arthritis. Lancet 1964; 2(7349): 17-8.
    • (1964) Lancet , vol.2 , Issue.7349 , pp. 17-18
    • Powell, E.D.1    Field, R.A.2
  • 131
    • 0015463110 scopus 로고
    • Diabetic retinopathy and salicylates
    • Carroll WW, Geeraets WJ. Diabetic retinopathy and salicylates. Ann Ophthalmol 1972; 4(12): 1019-45.
    • (1972) Ann Ophthalmol , vol.4 , Issue.12 , pp. 1019-1045
    • Carroll, W.W.1    Geeraets, W.J.2
  • 132
    • 0035409354 scopus 로고    scopus 로고
    • Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin
    • Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 2001; 50(7): 1636-42.
    • (2001) Diabetes , vol.50 , Issue.7 , pp. 1636-1642
    • Kern, T.S.1    Engerman, R.L.2
  • 133
    • 33847037432 scopus 로고    scopus 로고
    • Salicylatebased anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy
    • Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS. Salicylatebased anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007; 56(2): 337-45.
    • (2007) Diabetes , vol.56 , Issue.2 , pp. 337-345
    • Zheng, L.1    Howell, S.J.2    Hatala, D.A.3    Huang, K.4    Kern, T.S.5
  • 134
    • 0024500488 scopus 로고
    • Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial
    • The DAMAD Study Group
    • The DAMAD Study Group. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. Diabetes 1989; 38(4): 491-8.
    • (1989) Diabetes , vol.38 , Issue.4 , pp. 491-498


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.